TENAX THERAPEUTICS Trademark

Trademark Overview

On Thursday, August 28, 2014, a trademark application was filed for TENAX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TENAX THERAPEUTICS trademark a serial number of 86379553. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 5, 2018. This trademark is owned by Oxygen Biotherapeutics, Inc.. The TENAX THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of traumatic brain injury, lung disorders, respiratory failure, heart failure, stroke, low cardiac output syndrome, septic shock, traumatic brain injury, kidney failure, acute critical care conditions, tissue ischemia, burns, wounds, sickle cell disease, acne and dandruff; Pharmaceutical preparations for improving muscle contraction; Pharmaceutical preparations for increasing inotropic state; Pharmaceutical preparations for improving dilation of blood vessels
tenax therapeutics

General Information

Serial Number86379553
Word MarkTENAX THERAPEUTICS
Filing DateThursday, August 28, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 5, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 4, 2015

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"THERAPEUTICS"
Description of MarkThe mark consists of the word "TENAX" with a curved line through the letters "X" and "A", above the word "THERAPEUTICS".
Goods and ServicesPharmaceutical preparations for the treatment of traumatic brain injury, lung disorders, respiratory failure, heart failure, stroke, low cardiac output syndrome, septic shock, traumatic brain injury, kidney failure, acute critical care conditions, tissue ischemia, burns, wounds, sickle cell disease, acne and dandruff; Pharmaceutical preparations for improving muscle contraction; Pharmaceutical preparations for increasing inotropic state; Pharmaceutical preparations for improving dilation of blood vessels

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 10, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTENAX THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMORRISVILLE, NC 27560
Party NameTENAX THERAPEUTICS, INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressMORRISVILLE, NC 27560
Party NameOxygen Biotherapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMorrisville, NC 27560

Trademark Events

Event DateEvent Description
Monday, November 5, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 5, 2018ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 20, 2018ASSIGNED TO EXAMINER
Saturday, March 31, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 30, 2018EXTENSION 5 GRANTED
Wednesday, March 28, 2018EXTENSION 5 FILED
Wednesday, March 28, 2018TEAS EXTENSION RECEIVED
Friday, September 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 6, 2017EXTENSION 4 GRANTED
Wednesday, September 6, 2017EXTENSION 4 FILED
Wednesday, September 6, 2017TEAS EXTENSION RECEIVED
Friday, March 10, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 8, 2017EXTENSION 3 GRANTED
Wednesday, March 8, 2017EXTENSION 3 FILED
Wednesday, March 8, 2017TEAS EXTENSION RECEIVED
Thursday, September 29, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 28, 2016EXTENSION 2 GRANTED
Thursday, September 8, 2016EXTENSION 2 FILED
Sunday, September 25, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 8, 2016TEAS EXTENSION RECEIVED
Thursday, March 10, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 8, 2016EXTENSION 1 GRANTED
Tuesday, March 8, 2016EXTENSION 1 FILED
Tuesday, March 8, 2016TEAS EXTENSION RECEIVED
Wednesday, January 27, 2016TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 25, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 25, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, October 17, 2015NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 29, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 4, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 4, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 15, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 26, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, June 25, 2015ASSIGNED TO LIE
Tuesday, June 9, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 29, 2015EXAMINER'S AMENDMENT ENTERED
Friday, May 29, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 29, 2015EXAMINERS AMENDMENT E-MAILED
Friday, May 29, 2015EXAMINERS AMENDMENT -WRITTEN
Monday, December 15, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 15, 2014NON-FINAL ACTION E-MAILED
Monday, December 15, 2014NON-FINAL ACTION WRITTEN
Thursday, December 11, 2014ASSIGNED TO EXAMINER
Wednesday, October 8, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 11, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, September 10, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, September 1, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

therapeutics tenax preparations pharmaceutical failure improving injury brain traumatic dandruff acne disease